Inactive Instrument
Quotes Epigenomics AG Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Stock exchange
Deutsche Boerse AG- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ECX | 0.9000EUR | -1.10% | 1.26K € | ||
Börse Stuttgart
| ECX | 0.9000EUR | 0.00% | 58.5 € | |
|
Boerse Muenchen
| ECX | 0.9500EUR | 0.00% | 0 € |
Basic data
Market Cap (EUR)
798,048
Market Cap (USD)
915,298
Net sales (EUR)
24,000
Net sales (USD)
27,526
Free-Float
70.75%
Free-Float capitalization (EUR)
564,648
Free-Float capitalization (USD)
647,606
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -0.59% | +10.04% | +397.07% | +102.38% | 4.62B | |
| -2.62% | +12.43% | +108.53% | +437.84% | 4.45B | |
| +4.33% | +0.75% | +21.72% | +83.72% | 3.34B | |
| +0.93% | +3.74% | +272.38% | +601.03% | 2.81B | |
| +6.75% | +15.41% | -16.39% | -19.04% | 2.43B | |
| -2.98% | +10.96% | +56.60% | - | 1.78B | |
| +0.89% | +6.73% | +28.20% | +62.00% | 1.13B | |
| +2.87% | +7.26% | +165.56% | -28.59% | 1.07B | |
| +5.23% | +1.37% | -15.35% | +65.52% | 604M | |
| Average | +1.65% | +7.58% | +113.15% | +163.11% | 2.22B | |
| Weighted average by Cap. | +0.95% | +8.64% | +153.61% | +216.27% |
Historical Quotes: Epigenomics AG
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- ECX Stock
- Stock
- Quotes Epigenomics AG
Select your edition
All financial news and data tailored to specific country editions
